To implement the relevant provisions of the Drug Administration Law and theVaccine Administration Law, strengthen the management of records and data of drug R&D, production, distribution and use, and ensure that relevant information is true, accurate, complete and traceable, NMPA has organized to formulate the Requirements for the Management of Drug Records and Data (Interim), which was issued on June 24, 2020 and shall come into force as of December 1, 2020.